Hikma Pharmaceuticals Plc  

(Public, LON:HIK)   Watch this stock  
Find more results for HIK
1,940.00
-40.00 (-2.02%)
Real-time:   10:46AM GMT+1
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,933.00 - 1,975.00
52 week 1,564.00 - 2,617.00
Open 1,970.00
Vol / Avg. 97,121.00/415,160.00
Mkt cap 3.84B*
P/E 21.27
Div/yield 9.90/0.73*
EPS 0.91*
Shares 198.88M
Beta     -
Inst. own     -
*GBP
May 15, 2015
Hikma Pharmaceuticals PLC Annual Shareholders Meeting (Estimated) Add to calendar
May 14, 2015
Hikma Pharmaceuticals PLC Annual Shareholders Meeting - 11:00AM GMT+1 - Add to calendar
May 7, 2015
Hikma Pharmaceuticals PLC at Deutsche Bank Health Care Conference - 6:30PM GMT+1 - Add to calendar
Mar 30, 2015
Hikma Pharmaceuticals PLC at Barclays PLC, Citi, HSBC and National Bank of Abu Dhabi Fixed Income Investor Roadshow - Germany
Mar 30, 2015
Hikma Pharmaceuticals PLC at Barclays PLC, Citi, HSBC and National Bank of Abu Dhabi Fixed Income Investor Roadshow - London
Mar 29, 2015
Hikma Pharmaceuticals PLC at Barclays PLC, Citi, HSBC and National Bank of Abu Dhabi Fixed Income Investor Roadshow - Abu Dhabi
Mar 29, 2015
Hikma Pharmaceuticals PLC at Barclays PLC, Citi, HSBC and National Bank of Abu Dhabi Fixed Income Investor Roadshow - Dubai
Mar 27, 2015
Hikma Pharmaceuticals PLC at Barclays PLC, Citi, HSBC and National Bank of Abu Dhabi Fixed Income Investor Roadshow - London
Mar 11, 2015
Full Year 2014 Hikma Pharmaceuticals PLC Earnings Call
Mar 11, 2015
Full Year 2014 Hikma Pharmaceuticals PLC Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 14.78% 18.94%
Operating margin 22.10% 27.00%
EBITD margin - 33.51%
Return on average assets 10.26% 13.49%
Return on average equity 18.53% 25.11%
Employees 7,139 -
CDP Score - 82 B

Address

13 Hanover Square
LONDON, W1S 1HL
United Kingdom - Map
+44-20-73992760 (Phone)
+44-20-73992761 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Hikma Pharmaceuticals PLC is the United Kingdom-based Company that is engaged in the manufacting and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The Company operates in three business segments: Branded, Injectables, and Generics. The Company�s branded pharmaceuticals are manufactured at facilities located in Jordan, Algeria, Saudi Arabia, Egypt, Tunisia and Morocco. Its Branded business sells 50 under-licensed products. The Company�s Generics business operates as West-Ward Pharmaceuticals, a domestic marketer and manufacturer of generic pharmaceutical products, selling 50 generic compounds in 122 dosage forms and strengths. Its injectable business markets 171 branded and non-branded injectable products in 302 dosage strengths and forms, including fourteen in-licensed products.

Officers and directors

Said Darwazah Chairman of the Board, Chief Executive
Age: 57
Mazen Samih Talib Darwazah Executive Vice Chairman of the Board; President and Chief Executive Officer of MENA and Emerging Markets
Age: 56
Khalid Nabilsi Chief Financial Officer
Michael Raya President and Chief Executive Officer, USA
Ibrahim Jalal Senior Corporate Vice President - Technical Affairs
Majda Labadi Corporate Vice President - Human Resources
Susan Ringdal Vice President - Corporate Strategy and Investor Relations
Riad Mishlawi EU Vice President and Global Head - Injectables
Fadi Nassar Corporate Vice President - Active Pharmaceutical Ingredients
Ragheb Al-Shakhshir Corporate Vice President - Research & Development